Sertrolast Tablets

This product is a thromboxane A2 receptor antagonist, which can inhibit the vasoconstriction reaction caused by various chemical transmitters (thromboxane A2, leukotriene D4, platelet activating factor), inhibit the immediate and delayed allergic reactions induced by antigen inhalation, and improve lung function.

±-ζ-(2,4,5-trimethyl-3,6-dicarbonyl-1,4-cyclohexadien-1-yl)phenylheptanoic acid

This product is a yellow tablet.

This product is suitable for the treatment of mild and moderate bronchial asthma.

Oral administration: Adults take 2 tablets (2 x 40 mg) once a day, or as directed by a physician. This product should be taken after dinner.

Very few patients (less than 0.1%) occasionally experience liver dysfunction accompanied by jaundice, elevated ALT and AST, and there are also reports of acute hepatitis patients, all of which should be treated by discontinuation of the drug. A small number of patients (within 0.1-5%) may experience: 1. Allergic symptoms, such as rash and itching, which can be treated by discontinuation of the drug; 2. Digestive system, such as nausea, vomiting, loss of appetite, stomach discomfort, abdominal pain, diarrhea, constipation, thirst; 3. Blood system: epistaxis, subcutaneous hemorrhage, anemia, eosinophilia; 4. Mental system: drowsiness, headache, dizziness, etc.; 5. Others: fatigue, edema, palpitations.

It is contraindicated for people who are allergic to this product. It is contraindicated for pregnant women.

Precautions during pregnancy and lactation: Contraindicated for use by pregnant women.

Keep in a light-proof and airtight container. Valid for two and a half years.

40mg

Nanjing Pharmaceutical FACTORY Co., Ltd.

• Founded in:

  1991-07-11

• Address:

  No. 26, Xingang Avenue, Nanjing Economic and Technological Development Zone

• Tax NO.:

  91320192134908655F

• Registered Funds:

  200.8 million yuan

• Website:

  Log in to view

• Email:

  Log in to view